The Oxford-AstraZeneca is hailed as a cheap and easy jab to fight COVID-19. But a series of corporate stumbles have clouded it's promise, and science backed results.
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
